Zhonghua fu chan ke za zhi · 2000
[Measurement of macrophage colony-stimulating factor during in-vitro fertilization and embryo transfer cycles].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Quan S, Wan L, Song L
Аннотация
OBJECTIVE: To explore the influences of macrophage colony-stimulating factor (M-CSF) on follicle development, ovulation, fertilization and embryo quality during in-vitro fertilization and embryo transfer (IVF-ET) cycles.
METHODS: 36 patients underwent 54 cycles of controlled ovarian hyperstimulation by gonadotropin-releasing hormone agonist-human menopausal goudotropin-human chorionic gonadotropin for IVF-ET program. M-CSF concentrations in serum were measured at early follicular phase, mid-follicular phase and the day of oocyte retrieval by enzyme-linked immunosorbent assay. Follicular fluid (FF) on the day of egg retrieval was also measured for M-CSF concentration.
RESULTS: M-CSF concentration in serum gradually increased throughout ovarian hyperstimulation and reached a peak on the day of oocyte retrieval. M-CSF concentration in FF was significantly higher than that in serum on the same day (P < 0.01). The M-CSF concentration in FF from follicles where oocytes could be retrieved, fertilized or with a diameter > or 16 mm, volume > or 2 ml, was significantly higher than those from follicles where oocyte could not be retrieved, fertilized or with a diameter < 16 mm, volume < 2 ml, respectively (P < 0.01). However, there was no significant difference in M-CSF concentration of FF between high and low embryo grade groups (P > 0.05).
CONCLUSIONS: M-CSF may play an important role as an intraovarian regulator in the process of follicle development, maturation and ovulation. Therefore, M-CSF may exert an effect on fertilization process but not on the embryo quality.
METHODS: 36 patients underwent 54 cycles of controlled ovarian hyperstimulation by gonadotropin-releasing hormone agonist-human menopausal goudotropin-human chorionic gonadotropin for IVF-ET program. M-CSF concentrations in serum were measured at early follicular phase, mid-follicular phase and the day of oocyte retrieval by enzyme-linked immunosorbent assay. Follicular fluid (FF) on the day of egg retrieval was also measured for M-CSF concentration.
RESULTS: M-CSF concentration in serum gradually increased throughout ovarian hyperstimulation and reached a peak on the day of oocyte retrieval. M-CSF concentration in FF was significantly higher than that in serum on the same day (P < 0.01). The M-CSF concentration in FF from follicles where oocytes could be retrieved, fertilized or with a diameter > or 16 mm, volume > or 2 ml, was significantly higher than those from follicles where oocyte could not be retrieved, fertilized or with a diameter < 16 mm, volume < 2 ml, respectively (P < 0.01). However, there was no significant difference in M-CSF concentration of FF between high and low embryo grade groups (P > 0.05).
CONCLUSIONS: M-CSF may play an important role as an intraovarian regulator in the process of follicle development, maturation and ovulation. Therefore, M-CSF may exert an effect on fertilization process but not on the embryo quality.